Health
Prior SARS-CoV-2 infection enhances Johnson and Johnson Ad26.COV2.S vaccine immunogenicity – News-Medical.Net
A new study reports that the Johnson and Johnson vaccine against COVID-19 shows enhanced efficacy when administered to individuals…
A new study reports that the single-dose Johnson and Johnson Ad26.COV2.S vaccine against coronavirus disease 2019 (COVID-19) shows enhanced efficacy when administered to individuals with pre-existing antibodies against the severe acute respiratory syndrome…
Continue Reading
-
Noosa News22 hours agoMoreton Bay oyster farm survives cyclone with help of wave wall innovation
-
Noosa News24 hours agoHelicopter pilots saving lives, providing food and fodder in flooded outback Queensland
-
General23 hours agoInternal Revenue Service starts cutting 20,000 workers
-
Noosa News23 hours agoMan killed, woman seriously injured in collision in Wongabel, Atherton Tablelands, Queensland